This is a Request for Information (RFI) for planning purposes only and is not a solicitation. The Department of Veterans Affairs seeks sources capable of providing an FDA-approved Gallium-68 PSMA agent, equivalent to Illuccix, for prostate cancer diagnosis. The performance location is the VA San Diego Healthcare System in California. The potential period of performance includes a base year from July to December 2026 and four option years running through 2030. The government provides estimated annual quantities for the agent but does not specify a budget.